J9277 – Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9277
- Long description
- Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph
- Short description
- Pembrolizumab 1mg berahyalur
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- April 1, 2026
- Last change
- April 1, 2026 – No change
Frequently asked questions
What is HCPCS code J9277?
J9277 is a HCPCS Level II code for injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph.
Does Medicare cover J9277?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9269 – Injection, tagraxofusp-erzs, 10 micrograms
- J9270 – Injection, plicamycin, 2.5 mg
- J9271 – Injection, pembrolizumab, 1 mg
- J9272 – Injection, dostarlimab-gxly, 10 mg
- J9273 – Injection, tisotumab vedotin-tftv, 1 mg
- J9274 – Injection, tebentafusp-tebn, 1 microgram
- J9275 – Injection, cosibelimab-ipdl, 2 mg
- J9276 – Injection, zanidatamab-hrii, 2 mg
- J9278 – Injection, carboplatin (avyxa), 1 mg
- J9280 – Injection, mitomycin, 5 mg
- J9281 – Mitomycin pyelocalyceal instillation, 1 mg
- J9282 – Mitomycin, intravesical instillation, 1 mg
- J9285 – Injection, olaratumab, 10 mg
- J9286 – Injection, glofitamab-gxbm, 2.5 mg
- J9289 – Injection, nivolumab, 2 mg and hyaluronidase-nvhy
- J9292 – Injection, pemetrexed dipotassium, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.